Abstract
Background: To estimate the clinical and economic impact of intensive care unit-acquired bloodstream infections in Taiwan.
Methods: The first episodes of intensive care unit-acquired bloodstream infections in patients ≥ 20 years of age in the Taiwanese population were identified in the National Health Insurance Research Database and in the Taiwan Nosocomial Infections Surveillance (2007-2015) dataset. Propensity score-matching (1:2) of demographic data, comorbidities, and disease severity was performed to select a comparison cohort from a pool of intensive care unit patients without intensive care unit-acquired infections from the same datasets.
Results: After matching, the in-hospital mortality of 14,369 patients with intensive care unit-acquired bloodstream infections was 44.38%, compared to 33.50% for 28,738 intensive care unit patients without bloodstream infections. The 14-day mortality rate was also higher in the bloodstream infections cohort (4,367, 30.39% vs. 6,860 deaths, 23.87%, respectively; p < 0.001). Furthermore, the patients with intensive care unit-acquired bloodstream infections had a prolonged length of hospitalization after their index date (18 [IQR 7–39] vs. 10 days [IQR 4–21], respectively; p < 0.001) and a higher healthcare cost (16,086 [IQR 9,706–26,131] vs. 10,731 US dollars [IQR 6,375–16,910], respectively; p < 0.001). The excessive hospital stay and healthcare cost per case were 12.77 days and 7,646 US dollars, respectively. Similar results were observed in subgroup analyses of various World Health Organization’s priority pathogens and Candida spp.
Conclusions: Intensive care unit-acquired bloodstream infections in critically ill patients were associated with increased mortality, longer hospital stays, and higher healthcare costs.